Select Page ::

Global Egg Phosphatidylcholine Industry: Sales, Revenue, Market Share and Competition by Manufacturer Covered in a Latest Research – Market Research…

Posted on November 8, 2019 by Prof Baldwin

Egg Phosphatidylcholine appear to regulate cholesterol absorption and inflammation.

Access Report Details at: https://www.themarketreports.com/report/global-egg-phosphatidylcholine-market-by-manufacturers-regions-type-and-application-forecast

Market share of global Egg Phosphatidylcholine industry is dominate by companies like Nutrasal, Avanti Polar Lipids, Lipoid, Natural Factors, Kewpie, NOF, Jena Bioscience, Vitamin Research Products and others which are profiled in this report as well in terms of Sales, Price, Revenue, Gross Margin and Market Share (2017-2018).

With the help of 15 chapters spread over 100 pages this report describe Egg Phosphatidylcholine Introduction, product scope, market overview, market opportunities, market risk, and market driving force. Later it provide top manufacturers sales, revenue, and price of Egg Phosphatidylcholine, in 2017 and 2018 followed by regional and country wise analysis of sales, revenue and market share. Added to above, the important forecasting information by regions, type and application, with sales and revenue from 2019 to 2024 is provided in this research report. At last information about Egg Phosphatidylcholine sales channel, distributors, traders, dealers, and research findings completes the global Egg Phosphatidylcholine market research report.

Market Segment by Regions, regional analysis covers:

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Columbia, etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers:

Choline

Serine

Inositol

Ethanolamine

Market Segment by Applications, can be divided into

Cosmetics

Pharmaceutical

Dietary Supplements

Purchase this premium research report at: https://www.themarketreports.com/report/buy-now/1491809

Table of Contents

1 Market Overview

2 Manufacturers Profiles

3 Global Egg Phosphatidylcholine Market Competitions, by Manufacturer

4 Global Egg Phosphatidylcholine Market Analysis by Regions

5 North America Egg Phosphatidylcholine by Countries

6 Europe Egg Phosphatidylcholine by Countries

7 Asia-Pacific Egg Phosphatidylcholine by Countries

8 South America Egg Phosphatidylcholine by Countries

9 Middle East and Africa Egg Phosphatidylcholine by Countries

10 Global Egg Phosphatidylcholine Market Segment by Type

11 Global Egg Phosphatidylcholine Market Segment by Application

12 Egg Phosphatidylcholine Market Forecast (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

Ask your report related queries at: https://www.themarketreports.com/report/ask-your-query/1491809

Read the rest here:
Global Egg Phosphatidylcholine Industry: Sales, Revenue, Market Share and Competition by Manufacturer Covered in a Latest Research - Market Research...

Vitamin Market Potential Growth, Share, Demand And Analysis Of Key Players- Research Forecasts To 2025 – BBC News Media

Posted on December 5, 2019 by Prof Baldwin

Latest Research : Egg Phosphatidylcholine Market 2019 || A Comprehensive Competitive Analysis By Top Companies, CAGR Status, Market Size and Forecast…

Posted on October 18, 2019 by Prof Baldwin

A Recent Research By MarketResearch.Biz On Egg Phosphatidylcholine Market Provides A Professional, In-depth, Comprehensive, and Well-designed Insights that can help you to make better business decisions

The globalEgg Phosphatidylcholine Marketis studied and analyzed with the help of a complete primary and secondary market research. The report provides broad industry data on the Egg Phosphatidylcholine market, such as size, forecasted growth, profitability, key players, market share and market trends will give you a high-level overview of Egg Phosphatidylcholine market opportunities. This report studies the global market size of Egg Phosphatidylcholine, especially focuses on the key regions like North America, Europe and Asia-Pacific, South America, Middle East, and Africa

The market size section gives the Egg Phosphatidylcholine market revenues, covering historic growth of the market as well as forecasting the future. Moreover, the report covers a host of company profiles, who are making a mark in the industry or have the potential to do so. The profiling of the players includes their market size, key product launches, information regarding the strategies they employ, and others.

The Leading key players covered in this study:Nutrasal, Inc., Avanti Lipids Polar, Inc., Lipoid GmbH, Harmony Whole Foods Market, Natural Factors Inc., Kewpie Corporation, NOF America Corporation, Jena Bioscience GmbH, Vitamin Research Products, LLC.

To Obtain All-Inclusive Information On Forecast Analysis Of GlobalEgg PhosphatidylcholineMarket, Request A Pdf Report Herehttps://marketresearch.biz/report/egg-phosphatidylcholine-market/request-sample

Egg Phosphatidylcholine Market: Market Segmentation

Global egg phosphatidylcholine market segmentation by application:SolubilizerMoisturizerEmulsifierOthers

Global egg phosphatidylcholine market segmentation by end use:CosmeticsPharmaceuticalsNutraceuticalOthers

In the end, The report also gives complete information regarding the research methodology of the Egg Phosphatidylcholine market.

High level Business Questions Answered and Covered in this Report: Heres a checklist

What is the market size of the Egg Phosphatidylcholine market at the global level?

Which is the preferred age group for targeting Egg Phosphatidylcholine for manufacturers?

What are the key factors driving, growth of the market?

What is the impact of the regulations on the growth of the Egg Phosphatidylcholine market?

Which is the leading country and region for the growth of the market?

What is the anticipated growth rate of the major regions during the forecast period?

How are the emerging markets for Egg Phosphatidylcholine expected to perform in the coming years?

Who are the major players operating in the global Egg Phosphatidylcholine market? What is the current market position of the players? Who are the emerging players?

Who are the major distributors, traders, and dealers operating in the Egg Phosphatidylcholine market?

For More Actionable Insights Into The Competitive Landscape Of Global Market, Get A Customized Report Herehttps://marketresearch.biz/report/egg-phosphatidylcholine-market/#inquiry

Research Methodology:

The report has been consolidated using three research methodologies. The first step centers around exhaustive primary and secondary researches, which includes an extensive collection of information on the Global Egg Phosphatidylcholine Market and the parent and peer market.

The next step involves validating the market size, estimations, findings, and assumptions with further precise information from industry experts. The report obtains a complete estimation of the market size with the help of bottom-up and top-down approaches. Finally, the report obtains the market estimation of all the segments and sub-segments using data triangulation and market breakup procedures.

About Us:

MarketResearch.Biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. The company offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations across the globe, and deliver our offerings in the shortest possible turnaround time.

Mr. Benni Johnson ([emailprotected])

MarketResearch.Biz (Powered By Prudour Pvt. Ltd.)

420 Lexington Avenue, Suite 300

New York City, NY 10170,

United States

Website:https://marketresearch.biz

Vitamin Research – UNIV OF WISCONSIN

Posted on March 17, 2017 by Prof Baldwin

Progress 10/01/06 to 09/30/11

Impacts The reproductive efficiency and health of animals, including humans, is clearly influenced by nutritional status. Rather than striving only to prevent overt nutrient deficiency, we need to begin to develop an understanding of "optimal" levels of a given nutrient to promote health. A detailed understanding of the physiological and molecular processes for which vitamins are needed is essential not only for optimizing human health, but also for determining how vitamin derivatives might be used in the treatment of human disease. For example, vitamin A compounds have shown promise in the prevention and treatment of cancer, as well as in the treatment of acne. However, the toxicity of many retinoids limits their use. Similar potential exists for the use of vitamin D analogs in a number of diseases, but the side effect, hypercalcemia, has been a major limitation to the advancement of these efforts. Thus, studies of new vitamin A analogs and non-calcemic vitamin D analogs may offer new approaches to the treatment of several disease states, including acne and cancer. Numerous patents that have issued or have been filed through the Wisconsin Alumini Research Foundation have arisen from these studies.

Publications

Progress 01/01/09 to 12/31/09

Outputs OUTPUTS: The overall focus of this work is the study of the fat-soluble vitamins A and D. Ongoing work in three project areas is described below. Project 1. Both nutritional and genetic approaches are being used to determine how and when vitamin A is needed for developing embryos, neonates and adults. Our laboratory has developed methods that enable the study of vitamin A function in both early and late embryonic processes, and more recently during postnatal life. When limiting amounts of atRA are provided after embryonic day (E) 10.5 in the rat, a highly reproducible and penetrant state of late fetal vitamin A-deficiency (VAD) is produced in the organs of developing fetuses. Using this method, we have recently shown that vitamin A is required for the initiation of meiosis in the female gonad. In addition, we have published a detailed characterization of the molecular events that are perturbed in the developing eye when insufficient vitamin A is present. We are also studying the function of several novel atRA responsive genes, and have shown that one of these genes (RAINB1 also known as Nav2) plays an essential role in neurite outgrowth, and in the development of the cranial nerves, eye, and brain. Project 2. Cellular and in vivo approaches are being used to address how the 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), exerts its antitumor effects. In collaboration with our colleagues at the OSU, we have shown that the carbon-linked 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), does not need to be hydrolyzed back to atRA to function in culture or in vivo. Further, 4-HBR is less toxic than 4-HPR, and appears to act by inducing ER stress-mediated responses. Work to further elucidate the cellular pathways that are altered by 4-HBR is underway, as are studies of its effects in developing embryos. Project 3. Additional studies in the lab are directed at developing improved vitamin analogs for the treatment of acne. Using the Rhino mouse as a model, the ability of compounds to produce a reduction in comedone size is being studied. Whereas all vitamin D analogs appear to induce thickening of the epidermis, we have identified a unique subset of analogs that also induce comedolysis. Studies are underway to determine how vitamin D compounds act to produce these effects. PARTICIPANTS: Angela See, Postdoctoral fellow; current employment Nimblegen; Hui Li, Postdoctoral fellow; Melissa Rohrer, Posdotoral fellow; Elizabeth McNeill, completed PhD; Nirca Nieves, completed PhD; Allyson Anding, PhD training ongoing; Mark Marzinke, PhD training ongoing TARGET AUDIENCES: Not relevant to this project. PROJECT MODIFICATIONS: Not relevant to this project.

Impacts The reproductive efficiency and health of animals, including humans, is clearly influenced by nutritional status. Rather than striving only to prevent overt nutrient deficiency, we need to begin to develop an understanding of "optimal" levels of a given nutrient to promote health. A detailed understanding of the physiological and molecular processes for which vitamins are needed is essential not only for optimizing human health, but also for determining how vitamin derivatives might be used in the treatment of human disease. For example, vitamin A compounds have shown promise in the prevention and treatment of cancer, as well as in the treatment of acne. However, the toxicity of many retinoids limits their use. Similar potential exists for the use of vitamin D analogs in a number of diseases, but the side effect, hypercalcemia, has been a major limitation to the advancement of these efforts. Thus studies of new vitamin A analogs and non-calcemic vitamin D analogs may offer new approaches to the treatment of several disease states, including acne and cancer. Numerous patents that have issued or have been filed through the Wisconsin Alumini Research Foundation have arisen from these studies.

Publications

Progress 01/01/08 to 12/31/08

Outputs OUTPUTS: The overall focus of this work is the study of the fat-soluble vitamins A and D. Ongoing work in three project areas are described below. Project 1. Both nutritional and genetic approaches are being used to determine how and when vitamin A is needed for developing embryos, neonates and adults. Our laboratory has developed methods that enable the study of vitamin A function in both early and late embryonic processes, and more recently during postnatal life. Our recently published work shows that when limiting amounts of atRA are provided after embryonic day (E) 10.5 in the rat, a highly reproducible and penetrant state of late fetal vitamin A-deficiency (VAD) is produced in the organs of developing fetuses. This work shows that a large number of organ systems are adversely affected, including the eye. The optic fissure does not close, and severe folding and collapse of the retina is observed at E18.5. In our most recent work, we show that coloboma and retinal folding represent distinct VAD-dependent effects. The downregulation of Pitx2 in VAD may be related to the failure of the optic fissure to close, whereas a reduction in cyclin D1 and the cell adhesion molecules, N-cadherin and B-catenin, may play a role in the retinal thinning, folding and collapse observed in late VAD fetuses. We are also studying the function of several novel atRA responsive genes, and have found that one of these genes (RAINB1) plays an essential role in neurite outgrowth, and in the development of the cranial nerves, eye, and brain. Project 2. Cellular and in vivo approaches are being used to address how the 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), exerts its antitumor effects on cancer cells. In collaboration with our colleagues at the OSU, we have found that the carbon-linked 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), does not need to be hydrolyzed back to atRA to function in culture or in vivo. Our studies also indicate that 4-HBR is less toxic than 4-HPR. Recently, we reported that 4-HBR rapidly induces ER stress-mediated responses and this may represent a mechanism whereby this compound produces its chemotherapeutic effects. Work to further elucidate the cellular pathways that are altered by 4-HBR is underway. Studies of additional nonhydrolyzable compounds, including glucuronide and glucose derivatives of 4-HBR are also ongoing. Project 3. Additional studies in the lab are directed at developing improved vitamin analogs for the treatment of acne. Using the Rhino mouse as a model, the ability of compounds to produce a reduction in comedone size is being studied. We have identified a specific subset of vitamin D analogs that are effective in this model. Studies are underway to determine how vitamin D compounds act to induce comedolysis. PARTICIPANTS: See - PhD received 2008: Knutson - PhD received 2008 Muley - completed postdoctoral training; McNeill - PhD in progress TARGET AUDIENCES: Not relevant to this project. PROJECT MODIFICATIONS: Not relevant to this project.

Impacts The reproductive efficiency and health of animals, including humans, is clearly influenced by nutritional status. It is becoming abundantly clear that rather than striving only to prevent overt nutrient deficiency, that we need to begin to develop an understanding of "optimal" levels of a given nutrient to promote health. A detailed understanding of the physiological and molecular processes for which vitamins are needed is essential not only for optimizing human health, but also for determining how vitamin derivatives might be used in the treatment of human disease. For example, vitamin A compounds have shown promise in the prevention and treatment of cancer, as well as in the treatment of acne. However, the toxicity of many retinoids limits their use. Similar potential exists for the use of vitamin D analogs in a number of diseases, but the side effect, hypercalcemia, has been a major limitation to the advancement of these efforts. Thus studies of new vitamin A analogs and non-calcemic vitamin D analogs may offer new approaches to the treatment of several disease states, including acne and cancer. Numerous patents that have issued or have been filed through the Wisconsin Alumini Research Foundation have arisen from these studies.

Publications

Progress 01/01/07 to 12/31/07

Outputs OUTPUTS: The overall focus of this work is the study of the fat-soluble vitamins A and D. Ongoing work in three project areas is described below. Project 1. Both nutritional and genetic approaches are being used to determine how and when vitamin A is needed for developing embryos. Our laboratory has developed methods that enable the study of vitamin A function in both early and late embryonic processes. Using this model, we have shown that vitamin A plays a critical early role in patterning the heart, hindbrain and axial skeleton. Our recently published work shows that when limiting amounts of atRA are provided after embryonic day 10.5 in the rat, a highly reproducible and penetrant state of late fetal vitamin A-deficiency (VAD) is produced in the organs of developing fetuses. These fetuses also display anteriorization of cervical regions of the skeleton and novel posteriorization events at the thoracic and sacral levels, and also show sternal and pelvic malformations not previously observed in genetic models. We are now using these nutritional models to explore the molecular mechanisms that are disrupted by embryonic vitamin A-deficiency. We are also studying the distribution and function of novel atRA responsive genes, and have found that one of these genes (RAINB1) plays an essential role in neurite outgrowth. Project 2. Cellular and in vivo approaches are being used to address how the 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), exerts its antitumor effects on cancer cells. In collaboration with our colleagues at the OSU, we have found that the carbon-linked 4-HPR analog (4-HBR) does not need to be hydrolyzed back to atRA to function in culture or in vivo. Studies of the efficacy 4-HBR in chemotherapy of DMBA-induced mammary tumors in the rat show that the non-hydrolysable analog is equally effective in reducing tumor size and number, and does so without reducing blood retinol levels, an undesirable side affect associated with the use of the parent compound, 4-HPR. Although 4-HBR can bind and transactivate RARs, this is not required for it to induce cell death. Recently, we reported that 4-HBR rapidly induces ER stress-mediated responses and may represent a mechanism whereby this compound produces its chemotherapeutic effects. Project 3. Additional studies in the lab are directed at developing improved vitamin analogs for the treatment of disease. One example is the use of retinoids for the treatment of acne. A major limitation to current oral therapy is teratogenic liability. As a potential improvement, we are studying sterically hindered vitamin A analogs. Using the Rhino mouse as a model, the ability of compounds to produce a reduction in comedone size is being studied. We have also found that some vitamin D analogs are effective in this model. Studies are underway to determine whether these approaches may offer any advantage to existing therapies. PARTICIPANTS: J. Ahrens, Research Specialist M. Kaiser, Senior Research Specialist In Training E. McNeill, Research Asst A. See, Research Asst N. Nieves, Research Asst A. Anding, Research Asst D. Knutson, Research Asst TARGET AUDIENCES: Biochemical, Cellular and Molecular and Medical Research Communities, with the Intent of Increasing Knowledge, as well as, to Capitalize on the Translational Value of this Research.

Publications

The rest is here:
Vitamin Research - UNIV OF WISCONSIN

Carson City nutrition factory to collaborate education with products – Nevada Appeal

Posted on August 3, 2017 by Prof Baldwin

Maria Watson wants Carson City to know she's back in business and is determined to bring the community quality health education, along with the relaunch of her company.

Formerly known as Vitamin Research Products, the CEO and president is reintroducing her natural vitamin supplement line as American Nutritional Products after a two year hiatus.

From stress relievers to belly busters, Watson's multivitamin products are manufactured with formulas containing plant-based ingredients, FDA approved.

Now that she's returned, she hopes to connect with the local community such as schools, churches, and other organizationsto teach the benefits of a healthy lifestyle and how to achieve it, while promoting her product.

Specifically, she hopes to target families and single parents, as nearly a third of the country spends dollars on fast-food and restaurant services, according to USDA.

Whether seminars take place at community colleges, health centers, or even at her facility, Watson hopes to fulfill one's health goals and produce new jobs in the area.

"It's been a painful and long journey," she said. "But this community helped us the first time and I want to educate as a way to give back."

When her company used to be Vitamin Research, Watson and her husband, Ron, supervised the facility on Highway 50 East in 2012, before constructing a larger building at 4610 Arrowhead Drive.

Back then, the company employed 127 people and packaged at least 3,000 products per day.

However, regulatory climate became a concern, to a point where the private equity group supporting Watson's company announced closure in July 2015. That closure led to the closure of Vitamin Research.

Now with 23 returning employees, Watson is preparing to get her manufacturing business up and running under the new name.

"My dream came true, but the rooms are empty." she said.

As for Watson's longtime customers, they're elated over the news of the original founder's return.

Jana Kay of Reno said she appreciates the natural ingredients the company uses in the multivitamins, as she couldn't find desired quality products in grocery stores or pharmacies.

"She's on a mission and wants to educate peoplewe need to educate people. That's why I was inspired to study nutrition and psychology in college, and learn about eating disorders within mental health."

Although Watson is a nutritional guru, what truly inspired her to get into the industry was her son, Josh, whom died at the age of 3 in 1987.

"He died in a car accident caused by a drunk driver, his babysitter," she said. "When he died, I gained 199 pounds and went through depression. But I knew I couldn't be like this foreverI believed I could change the world with my passion, and I still feel that way."

Watson is developing a plan for international collaboration. She connected with Deborah Torres Patel, a high prolific communication coach based out of Singapore.

Patel is known for mentoring best selling authors, entrepreneurs and leaders of Fortune 500 companies, and numerous celebrities in 79 countries.

Patel has never been to Carson City until last month when she met with Maria to help her develop a draft on how to combine health and education within the company.

One of Watson's ideas is to teach ways to relieve stress and anxietywith public speaking being a start.

"84 percent of first-time impressions is based on your tone of voice," Patel said. "It also affects how you feel and that's why I created my system to find your voice; you only get one chance to make a first impression."

Patel and Watson also discussed ways to collaborate education with new products, such as consumables or water with a natural ingredients to support energy boosts.

"It's about essential integrity and work," Watson said. "Why not amplify that in Carson City? People that live here are active. I want to educate those that will listen."

Watson advises the public to watch for future job announcements as the company grows.

For more information, contact Watson at 775-720-0028 or maria.watson@anp-nv.com.

Continue reading here:
Carson City nutrition factory to collaborate education with products - Nevada Appeal

Health Products Holdings has acquired … – Nature’s Products

Posted on March 6, 2018 by Prof Baldwin

Sunrise, FL ( August 31st, 2015) Health Products Holdings, LLC (HPH) has acquired from Vitamin Research Products, LLC all of its brands and related assets, including the well-known direct-to-consumer brands Vitamin Research Products (VRP), True Health (TH), and Health Resources (HR).

All three brands complement HPHs existing direct-to-consumer portfolio of brands, which included Iceland Health, Blessed Herbs, and Nutri-Health Supplements.

VRP brings market-leading products and significant talent that will partner well with our current brands, and provide customers exciting new choices to meet their specific health needs, now and in the future, said Tom Callahan, President of the direct-to-consumer business for HPH.

The entire VRP marketing team is thrilled to be joining forces with HPH. We look forward to multiple opportunities to grow our brands and build our leadership position in the direct-to-consumer nutritional supplement industry, said Kelly Cleary, formerly with VRP and now VP of Direct-to-Consumer Marketing for the combined business.

Added Mike Burroughs, now VP of IS and Digital Marketing, I believe VRP will benefit greatly from the additional financial and operational resources HPH will provide. We are very excited about the growth potential of our new, combined business.

HPHs direct-to-consumer team now combines some of the very best national talent in the industry across the catalog and digital marketing space with over a century of cumulative experience in direct-to-consumer marketing, hundreds of thousands of active customers, and over 400 unique supplement formulations to serve them.

This is the second acquisition in the past 10 months for Health Products Holdings as it continues to aggressively strengthen capabilities and expand its branded product portfolio across different areas of the nutritional supplements market, covering a broad portfolio of products across all channels.

About Health Product Holdings, LLC

Health Products Holdings, LLC, previously known as Natures Products, Inc., was founded in 1986 as a full service, GMP certified, contract manufacturer of consumer healthcare products in Sunrise, Florida. In addition to contract manufacturing, HPH now owns, produces, and markets its own portfolio of brands including Rainbow Light, Champion Nutrition, Iceland Health, Nutri-Health Supplements, Sedona Labs, Sedona Pro, Blessed Herbs and VitalStyle. HPH currently employs over 400 employees and offers a wide range of formulations, dosage forms, and manufacturing and packaging capabilities. Also, HPH has several affiliated businesses globally that expand the breadth of its capabilities and dosage forms beyond the nutritional supplement area. More information about Health Product Holdings can be found at http://www.hph-llc.com.

About Vitamin Research Products

Since Vitamin Research Products opened their doors in 1979, their mission has been to deliver the finest nutritional supplements and empower their customers to take charge of their own health. Every supplement offered by Vitamin Research Products (VRP) is developed and vetted by a staff of physicians, PhDs, nutritionists and individuals with decades of experience in product formulation. To ensure the best quality, all products are made with a careful selection of raw materials and comply with Current Good Manufacturing Practices (CGMPs). Vitamin Research Products merged with Health Resources and True Health in 2010. For more information on the brands of Vitamin Research Products, please visit their websites at http://www.vrp.com, http://www.truehealth.com, and http://www.healthresources.net.

Go here to read the rest:
Health Products Holdings has acquired ... - Nature's Products

Vitamins Information Center – A comprehensive database of …

Posted on May 19, 2015 by Prof Baldwin

your source for the latest research on vitamins, minerals and whole-food nutrition

The Vitamins & Nutrition Center is a leading authority on vitamins, minerals and whole-food nutrition. Explore the latest research, detailed profiles on every vitamin and mineral, what to look for in a multivitamin, and thousands of informative articles on how to achieve and maintain a healthy lifestyle.

Vitamin Research Center We have gathered hundreds of published research on vitamins and presented them to you in plain English. See what the latest clinical research says about your favorite vitamins and the positive impact that vitamins can have on your health and disease prevention.

THE GREAT DEBATE: LIQUID VITAMINS VS. PILLS

What kind of vitamins should you be taking? Liquid form? Pill from? Decide for yourself.

HealthyLiving Blog Join the conversation on all things health-related.

Detailed information on the 46 most common vitamins, including Vitamin A, Vitamin B, Vitamin C, Vitamin D and Vitamin E. Minerals and many herbs are also profiled.

Learn More

We have gathered hundreds of published research on vitamins and presented them to you in plain English. See the latest clinical research.

Learn More

View original post here:
Vitamins Information Center - A comprehensive database of ...

Vitamin Research Products, LLC: Private Company …

Posted on September 5, 2015 by Prof Baldwin

Vitamin Research Products, LLC manufactures and supplies herbal and nutritional supplements. Its products include botanicals and herbs, health interest formulas, minerals, specialty supplements, vitamins, and miscellaneous products. The company also offers anti-inflammatory, antioxidants, blood pressure, blood sugar, bone support, cholesterol, detoxification, digestive health, energy, hair/skin/nails, healthy aging and vitality, heart/cardiovascular, immune support, joint/muscle, memory/cognitive support, respiratory, stress/mood/sleep, thyroid health, vision, weight management, women's health, men's health, and multivitamin/multi-nutrient products. It sells its products through an online st...

4610 Arrowhead Drive

Carson City, NV89706

United States

Founded in 1979

Originally posted here:
Vitamin Research Products, LLC: Private Company ...

Nanomedicine Market Shares, Strategies and Forecast Worldwide, 2017 to 2023 – The Haitian-Caribbean News Network

Posted on November 27, 2020 by Prof Baldwin

Overview:

Nanomedicineis an offshoot of nanotechnology, and refers to highly-specific medical intervention at the molecular scale for curing diseases or repairing damaged tissues. Nanomedicine uses nano-sized tools for the diagnosis, prevention and treatment of disease, and to gain increased understanding of the complex underlying pathophysiology of the disease. It involves three nanotechnology areas of diagnosis, imaging agents, and drug delivery with nanoparticles in the 11,000 nm range, biochips, and polymer therapeutics.

Click Here to Get Sample Premium Report @https://www.trendsmarketresearch.com/report/sample/9807

Majority of nanomedicines prescribedcurrently, allow oral drug delivery and its demand is increasing significantly. Although these nanovectors are designed to translocate across the gastrointestinal tract, lung, and bloodbrain barrier, the amount of drug transferred to the organ is lower than 1%; therefore improvements are challenging. Nanomedicines are designed to maximize the benefit/risk ratio, and their toxicity must be evaluated not only by sufficiently long term in vitro and in vivo studies, but also pass multiple clinical studies.

Market Analysis:

The Global Nanomedicine Market is estimated to witness a CAGR of 17.1% during the forecast period 20172023. The nanomedicine market is analyzed based on two segments therapeutic applications and regions.

The major drivers of the nanomedicine market include its application in various therapeutic areas, increasing R&D studies about nanorobots in this segment, and significant investments in clinical trials by the government as well as private sector. The Oncology segment is the major therapeutic area for nanomedicine application, which comprised more than 35% of the total market share in 2016. A major focus in this segment is expected to drive the growth of the nanomedicine market in the future.

Regional Analysis:

The regions covered in the report are the Americas, Europe, Asia Pacific, and Rest of the World (ROW). The Americas is set to be the leading region for the nanomedicine market growth followed by Europe. The Asia Pacific and ROW are set to be the emerging regions. Japan is set to be the most attractive destination and in Africa, the popularity and the usage of various nano-drugs are expected to increase in the coming years. The major countries covered in this report are the US, Germany, Japan, and Others.

Therapeutic Application Analysis:

Nanomedicines are used as fluorescent markers for diagnostic and screening purposes. Moreover, nanomedicines are introducing new therapeutic opportunities for a large number of agents that cannot be used effectively as conventional oral formulations due to poor bioavailability. The therapeutic areas for nanomedicine application are Oncology, Cardiovascular, Neurology, Anti-inflammatory, Anti-infectives, and various other areas. Globally, the industry players are focusing significantly on R&D to gain approval for various clinical trials for future nano-drugs to be commercially available in the market. The FDA should be relatively prepared for some of the earliest and most basic applications of nanomedicine in areas such as gene therapy and tissue engineering. The more advanced applications of nanomedicine will pose unique challenges in terms of classification and maintenance of scientific expertise.

Key Players:

Merck & Co. Inc., Hoffmann-La Roche Ltd., Gilead Sciences Inc., Novartis AG, Amgen Inc., Pfizer Inc., Eli Lilly and Company, Sanofi, Nanobiotix SA, UCB SA and other predominate & niche players.

Competitive Analysis:

At present, the nanomedicine market is at a nascent stage but, a lot of new players are entering the market as it holds huge business opportunities. Especially, big players along with the collaboration with other SMBs for clinical trials of nanoparticles and compounds are coming with new commercial targeted drugs in the market and they are expecting a double-digit growth in the upcoming years. Significant investments in R&D in this market are expected to increase and collaborations, merger & acquisition activities are expected to continue.

Benefits:

The report provides complete details about the usage and adoption rate of nanomedicines in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, vertical players initiatives, government initiatives towards the nanomedicine adoption in the upcoming years along with the details of commercial drugs available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

Here is the original post:
Nanomedicine Market Shares, Strategies and Forecast Worldwide, 2017 to 2023 - The Haitian-Caribbean News Network

Botulinum Toxin Market to Reach US$ 8,718.7 Mn by 2026, Rise in number of cases of migraine is expected to drive the market – BioSpace

Posted on March 25, 2022 by Prof Baldwin

Albany NY, United States: The pressing need for quality and the identification of new applications sustains the competition in the global botulinum toxin market, says a recent report by Transparency Market Research (TMR). Most companies are focused on investing in research to identify new applications that could help them get advantage and gain a greater share in the global botulinum toxin market. At the same time, considering the current applications of the product, the need for high quality is invoking companies to adopt quality control techniques.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26132

On the other hand, rising requirement from specific sections of the healthcare industry is also promoting companies to step up production. The key players in the global botulinum toxin market are Allergan, Inc., Ipsen Group, Merz Pharma GmbH & Co. KGaA, Medytox, Inc., US Worldmed, LLC, Galderma, Metabiologics, Inc. (US), Lanzhou Institute of Biological Products Co. Ltd., and Revance Therapeutics.

According to TMR analysts, the global botulinum toxin market is expected to grow to a value of US$ 8,718.7 mn by the end of 2026. The analysts predict that this will happen as the market will grow a stable CAGR of 7.6% during the forecast period of 2018-2026.

Further, the botulinum toxin type A is expected to lead the global market for botulinum toxin during the forecast period. According to TMR report, the segment will alone account for 82% of the sales in the coming years, that will reap revenues of US$ 7,153.5 bn by the end of 2026. When it comes to geography, North America is predicted to be the leader in the coming years.

Request for Covid-19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=26132

Cosmetics and Neurology to Drive the Global Botulinum Toxin Market

Appearance has become an important aspect for every person today. So much so that people are willing to go an extra mile to make them look good. As a result, the need for products that solve problems regarding facial appearance are growing in importance. This stokes demand for products in the global botulinum toxin market. They are preferred because they are capable of fixing problems like spasticity and cervical dystonia.

On the other hand, the demand for products in the neurology section of healthcare is also looking promising. This section will stoke demand as the number of neurological cases rise and doctors find new treatment applications for the product. The product is known to be helpful for certain neurological conditions, and thus can influence demand in the global botulinum toxin market.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=26132

Research to Open New Applications in the Global Botulinum Toxin Market

While the applications of the product in the global botulinum toxin market has been found for the last three centuries, the need for fresh applications may help players find new hopes. As a result, the research and development section of most prominent players in occupied with studies aiming to find fresh applications. This will open new opportunities for the players in the global botulinum toxin market.

At the same time, players will also be looking at other key trends in the healthcare industry. This will help devise them strategies for the future and help give more credibility to the existing product line. Besides this, the growing health awareness among people, increasing access to information on social media, and the rising spending capacity in developed and emerging economies are other factors that will influence growth in the global botulinum toxin in the coming years.

The study presented above is based on a Transparency Market Research report titled Botulinum Toxin Market (Product Type - Botulinum Toxin Type A and Botulinum Toxin Type B; Application - Aesthetic, Therapeutics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026.

More Trending Reports by Transparency Market Research:

Microbiology Culture Market: According to the report, the microbiology culture market in the U.S. was valued at US$ 2.3 Bn in 2020 and is projected to expand at a CAGR of 7.8% from 2021 to 2031. Microbiology cultures play a pivotal role, and are required for quality testing and production in several industries such as biopharmaceuticals, food, water, biotechnology, cosmetic, agriculture, and various other industries.

Nanomedicine Market: Nanomedicine, a branch of nanotechnology, is used in the diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine improves medicine delivery by manipulating materials on a nanoscale. Hence, nanomedicine has aided in the treatment of various diseases. It is still in a nascent stage, with several products in the pipeline.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Rohit BhiseyTransparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

More:
Botulinum Toxin Market to Reach US$ 8,718.7 Mn by 2026, Rise in number of cases of migraine is expected to drive the market - BioSpace

Nanomedicine Against Malaria: Use of Poly-based Nanovectors for the Drug Delivery to Plasmodium – Video

Posted on March 29, 2014 by Prof Baldwin

Nanomedicine Against Malaria: Use of Poly-based Nanovectors for the Drug Delivery to Plasmodium
Speaker: Prof. Dr. Xavier Fernndez Busquets, PhD, Barcelona Centre for International Health Research, Research Associate, Institute for Bioengineering of Ca...

By: TAUVOD

Go here to see the original:

Nanomedicine Against Malaria: Use of Poly-based Nanovectors for the Drug Delivery to Plasmodium - Video

Panel – The Horizon of Nanomedicine and Targeted Drug Delivery – Video

Posted on March 29, 2014 by Prof Baldwin

Panel - The Horizon of Nanomedicine and Targeted Drug Delivery
"Clinical Nanomedicine Targeted Medicine", The European CLINAM ETPN Summit, June 23-26, 2013.

By: TAUVOD

Global Healthcare Nanotechnology (Nanomedicine) Market 2021 Production, Revenue, Price and Gross Margin Analysis with Forecasts Jumbo News – Jumbo…

Posted on June 11, 2021 by Prof Baldwin

Healthcare Nanotechnology (Nanomedicine) Market report provides strategic supports mentioned by the business specialists with market sources, amount of manufacturing cost structure, raw materials, forecasts, turnover, manufacturing outlays, latest market trends, labor cost, demands and much more. Healthcare Nanotechnology (Nanomedicine) market reportcovers a comprehensive market structure through the globe with an in-depth study of major dynamics (Drivers, Challenges, Opportunities).

Request a sample copy of the report https://www.absolutereports.com/enquiry/request-sample/14099195

Key Market Trends:

The Growth of Nanomedicine is Expected to Provide High Opportunities for the Treatment of Neurological Diseases, Over the Forecast Period

A large number of brain disorders with neurological and psychological conditions result in short-term and long-term disabilities. Recent years observed a significant number of research studies being published on methods for the synthesis of nanoparticle-encapsulated drugs within in vivo and in vitro studies. The insufficient absorbance of oral drugs administered for a range of neurological conditions, such as Alzheimers disease, Parkinson disease, tumor, neuro-AIDS, among others, opens up the necessity of nanomedicine with stem cell therapy. Some of the registered nanoparticles for the complex CNS treatment are a gold nanoparticle, lipid nanoparticle, and chitosan nanoparticles.

Other than neurological diseases, research-based progress was found in the treatment of cancers, with the scientific communities identifying new metabolic pathways to find better drug combination using nanomedicine.

North America is Expected to Hold the Largest Share in the Market

In the United States, several companies are closely observing the developments in nanostructured materials across various applications in the healthcare industry, including medical devices, to improve efficiency and efficacy. In the United States, the National Nanotechnology Initiative (NNI), which was initiated in 2000, is among the supreme bodies that manage all nanotechnology-related activities. Under the NNI, several agencies are working in collaboration with companies and universities. For instance, nano-manufacturing in Small Business Innovation Research (SBIR) programs were developed for both commercial and public use. Companies are targeting the treatment of several cancer types and infectious diseases through immunotherapy, where nanoemulsion vaccines and drugs play a significant role. In the United States, one of the major challenges associated with nanotechnology is the ability to integrate nanoscale materials into new devices and systems, along with an application of novel properties at the nano-level. Thus, most of the companies are investing in R&D. Nanotechnology is likely to play a significant role in the delivery of drugs. In the recent strategic plan presented by the NNI in 2016, several programs were identified to further advance the research and development programs, over the forecast period.

Market Overview:

Key Manufacturers Like

Scope of the Report:

Healthcare Nanotechnology (Nanomedicine) market report focuses on the latest trends in the global and regional spaces on all the significant components, including the capacity, cost, price, technology, supplies, production, profit, and competition. Moreover, the old data and present development of the Healthcare Nanotechnology (Nanomedicine) market have been given in the scope of the report. The latest trends, product portfolio, demographics, geographical segmentation, and regulatory framework of the Healthcare Nanotechnology (Nanomedicine) market have also been involved in the study.

Market Dynamics:

Inquire Or Share Your Questions If Any Before The Purchasing This Report https://www.absolutereports.com/enquiry/pre-order-enquiry/14099195

Key Questions Answered in Market Report:

Lastly, the Global Healthcare Nanotechnology (Nanomedicine) Market Research covers a complete market structure across the world with a comprehensive analysis of major key factors. This report provides planned orientations referred by the industry experts.

Purchase This Report (Price 4250 USD for single user license) https://www.absolutereports.com/purchase/14099195

Study objectives of Healthcare Nanotechnology (Nanomedicine) Market Report:

Detailed TOC of Healthcare Nanotechnology (Nanomedicine) Market Report 2019-2024:

1 INTRODUCTION1.1 Study Deliverables1.2 Study Assumptions1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS4.1 Market Overview4.2 Market Drivers4.2.1 Growing Prevalence of Cancer and Genetic and Cardiovascular Diseases4.2.2 Increasing Advancements in Nanoscale Technologies for Diagnostic Procedures4.2.3 Growing Preference for Personalized Medicines4.3 Market Restraints4.3.1 High Cost4.3.2 Stringent Regulations for Commercial Introduction4.4 Porters Five Forces Analysis4.4.1 Threat of New Entrants4.4.2 Bargaining Power of Buyers/Consumers4.4.3 Bargaining Power of Suppliers4.4.4 Threat of Substitute Products4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION5.1 By Application5.1.1 Drug Delivery5.1.2 Biomaterials5.1.3 Active Implants5.1.4 Diagnostic Imaging5.1.5 Tissue Regeneration5.1.6 Other Applications5.2 By Disease5.2.1 Cardiovascular Diseases5.2.2 Oncological Diseases5.2.3 Neurological Diseases5.2.4 Orthopedic Diseases5.2.5 Infectious Diseases5.2.6 Other Diseases5.3 Geography5.3.1 North America5.3.1.1 US5.3.1.2 Canada5.3.1.3 Mexico5.3.2 Europe5.3.2.1 France5.3.2.2 Germany5.3.2.3 UK5.3.2.4 Italy5.3.2.5 Spain5.3.2.6 Rest of Europe5.3.3 Asia-Pacific5.3.3.1 China5.3.3.2 Japan5.3.3.3 India5.3.3.4 Australia5.3.3.5 South Korea5.3.3.6 Rest of Asia-Pacific5.3.4 Middle East & Africa5.3.4.1 GCC5.3.4.2 South Africa5.3.4.3 Rest of Middle East & Africa5.3.5 South America5.3.5.1 Brazil5.3.5.2 Argentina5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE6.1 Company Profiles6.1.1 Sanofi SA6.1.2 Celegene Corporation6.1.3 CytImmune Sciences Inc.6.1.4 Johnson & Johnson6.1.5 Luminex Corporation6.1.6 Merck & Co. Inc.6.1.7 Nanobiotix6.1.8 Pfizer Inc.6.1.9 Starpharma Holdings Limited6.1.10 Taiwan Liposome Company Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Purchase This Report (Price 4250 USD for single user license) https://www.absolutereports.com/purchase/14099195

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other report :Aluminum Composite Panel (ACP) Market 2021-2026|Industry Growth, Development Strategy Pre and Post COVID-19, Worldwide Share, Size, Trends and Leading 20 Countries

Global Floral Water Market 2021: Industry Size, Growth, Segments, Revenue, Manufacturers and 2027 Forecast Research Report

Electric Bus Motor Market Analysis, Growth, Size, Share, Trends, Forecast, Supply Demand and Sales to 2026

Global Ice Cream Sticks Market 2027: Analysis by Product Types & Applications; Industry Top Players, Regions and Market Overview

Global Action Cameras Market Trend by 2026: Market Share, Segmentation, Market Growth and Competitive Landscape| Development Strategy Pre and Post COVID-19

Global PEG-150 Distearate Market 2021: by Product Types & Application, Top Manufacturer and Regional Analysis & Forecasts to 2027

Single Phase String Inverters Market Size, Share, Supply, Demand, Segments and Forecast 2021-2027 with COVID-19 Impact

Global Fireproof Sealant Market Share, Growth, Trend Analysis and Forecast from 2021-2027; Consumption Capacity by Volume and Production Value

Global Electromagnetic Coils Market 2021: Market Size, Share, Growth, Sales and Drivers Analysis Research Report 2027 with COVID-19 Impact

Global Warning Lights Market Research Report 2021: Size, Share, Growth, Trends and Forecast 2027

Global Sweet Whey Powder Market 2021|Growth Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries

Using Hybrid Nanoparticles to Deliver siRNA to Different Cell Types – AZoNano

Posted on October 31, 2021 by Prof Baldwin

Small (or short) interfering RNA (siRNA) is the predominant RNA interference (RNAi) tool used for instigating short-term silencing of protein-coding genes. Simply put, these are naturally occurring molecules that silence genes that encode specific proteins.

Image Credit: Love Employee/Shutterstock.com

This means that siRNA demonstrates significant potential for therapeutic use, given its capacity to control protein levels. However, one of the main drawbacks with siRNA is that researchers have had difficulty transmitting the molecules to the site of action in the body, the cytosol target of cells, as a result of the bodys immune response.1

To overcome the challenges associated with siRNA delivery, a team of researchers in the Netherlands has been working to develop hybrid nanoparticles that protect and transmit siRNA into target cells.

The system the team is using relies on a combination of liposomes and extracellular vesicles (EVs), which offer unique properties that package and protect siRNA against enzyme degradation.

The hybrid nanoparticles have a hydrophobic coating, thanks to the amphiphilic nature of the liposomes, which provides adequate shielding against the bodys immune response. Additionally, as EVs can easily pass through the outer membrane of a cell, the siRNA can be delivered to the site of action as intended.

The method employed by the researchers uses a dehydration technique to produce a thin lipid film which can then be rehydrated in a water-based mixture containing the EVs and siRNA. This then generates the liposome-EV-siRNA hybrid nanoparticles, which allows for a target-based delivery system.

We show that with increasing relativeEV content in our hybrids, uptake into cells becomes no longer dictated by the liposome content ... Thus, the EV surface molecules now seem to dictate which cells can internalize and process these hybrids.

Pieter Vader, Lead Researcher and Professor of Experimental Cardiology and Regenerative Medicine at the University of Utrecht

By modifying the hybrid formulation and experimenting with the liposome to EV ratio, the researchers found that it was possible to choose into which cells the siRNA would take. The team also discovered that various cell types had the capacity to receive the hybrid nanoparticles without a toxic or adverse reaction this included kidney, nerve and ovarian cell types.

The ability to alter the ratio of the liposome-EV-siRNA formulation is important in designing cell-targeting drugs as it potentially means that only diseased cell types would be targeted, reducing any risk or undesirable side-effects.

Thus, hybrid nanoparticles could integrate the functional properties of both liposomes and EVs and offer a best of both worlds particle for the therapeutic delivery of siRNA.1

The team also looked at the therapeutic outcome when the hybrid formulation was induced with EVs from a specific stem cell population: the results remarkably demonstrated recovery and healing in breast cancer cells. This shows great promise for the future of drug development, especially when designing new drugs that target cancer and degenerative diseases.

While the results of this study make significant strides for the use of hybrid nanoparticles in siRNA delivery, Vader and his team have some way to go before this treatment technology will be rolled out commercially.

Its too soon to tell where the most potential lies for our delivery system, but we know that EVs derived from progenitor cells have intrinsic regenerative properties ... Thus, regenerative medicine applications seem most logical.

Pieter Vader, Lead Researcher and Professor of Experimental Cardiology and Regenerative Medicine at the University of Utrecht

Despite being some way off commercial viability, this recent study clearly demonstrates future potential for using hybrid nanotechnology for effective drug delivery to treat various cancers and other difficult-to-treat, degenerative diseases.

Continue reading: Manifesting Multidisciplinary Nanomedicine Research with the Multiscale Metrology Suite

Evers, M., Et. Al. (2021) Functional siRNA Delivery by Extracellular VesicleLiposome Hybrid Nanoparticles.Advanced Healthcare Materials, Available at: https://doi.org/10.1002/adhm.202101202

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Originally posted here:
Using Hybrid Nanoparticles to Deliver siRNA to Different Cell Types - AZoNano

Nano-Medical Device Market To Set Phenomenal Growth and Trends By 2020-2027 | Stryker, PerkinElmer, Nektar Therapeutics, Affymetrix – Eurowire

Posted on November 19, 2020 by Prof Baldwin

Nanomedicine is the medical application of nanotechnology, and it ranges from the medicinal uses of nanomaterials and biological devices to nano electronic biosensors. However, current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials (materials whose structure is on the scale of nanometers, i.e., billionths of a meter). Also, functionalities can be added to nanomaterials by interfacing them with biological molecules or structures. Thus far, the integration of nanomaterials with biology has led to the development of diagnostic devices, contrast agents, analytical tools, physical therapy applications, and drug delivery vehicles.

The report provides study at global and regional level to provide comprehensive value market analysis for the years (2017 & 2018 Historic Years, 2019 Base Year and 2020-2027 Forecast Period). TheNano-Medical DeviceMarket research report is a wide-ranging study of current trends, market growth drivers, and restraints. Each market segment is broadly analyzed at a powdered level by region (North America, Europe, Asia Pacific, Middle East & Africa, and South& Central America) to provide thorough information on the global and regional level.

Download Sample PDF Brochure of this research study at https://www.theinsightpartners.com/sample/TIPRE00011102/

Top Leading Companies

1. Affymetrix2. Crucell N.V.3. Flamel Technologies S.A.4. Nektar Therapeutics5. Par Pharmaceutical companies Inc.6. PerkinElmer7. St.Jude Medical8. Starkey Hearing Technologies9. Starpharma Holdings limited10. Stryker Corporation

Our expert team is consistently working on updated data and information on the key players related business processes that value the market. For future strategies and predictions, we provide a special section regarding the COVID-19 situation.

The research provides answers to the following key questions:

The Insight Partners Nano-Medical Device Market Research Report Scenario includes:

Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00011102/

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Call: +1-646-491-9876

Email:[emailprotected]

Read the original:
Nano-Medical Device Market To Set Phenomenal Growth and Trends By 2020-2027 | Stryker, PerkinElmer, Nektar Therapeutics, Affymetrix - Eurowire

Global NANOTECHNOLOGY IN MEDICAL APPLICATIONS Statistics, CAGR, Outlook, and Covid-19 Impact 2016 The Bisouv Network – The Bisouv Network

Posted on February 14, 2021 by Prof Baldwin

Nanotechnology in Medical Applications: The Global Market

This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry are discussed with profiles of the leading 60+ companies, including recent merger and acquisition (M&A) activity. Five-year sales forecasts are provided for the national markets including the major therapeutic categories of products involved. Specific product categories quantified include diagnostics, cancer, CNS, anti-infective agents, cardiovasculars and anti-inflammatories.

Also Read:https://telegra.ph/Global-Dancewear-Market-Statistics-Development-and-Growth-2025-02-02

Report Includes:

Also Read: http://wiseguyes8.total-blog.com/global-china-digital-audio-broadcasting-dab-market-outlook-industry-analysis-and-prospect-2020-2026-22894697

An overview of the global markets for nanotechnology used in medical applications

Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022

A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications

Also Read: https://techsite.io/p/1944999

Information on many significant products in which the nano dimension has made a significant contribution to product effectiveness

A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine

Analysis of the markets dynamics, specifically growth drivers, inhibitors, and opportunities

Coverage of strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive marketSummary

Also Read:https://wiseguyreports12.blogspot.com/2021/02/global-china-digital-audio-broadcasting.html

Nano-enabled medical products began appearing on the market over a decade ago, and some have become best-sellers in their therapeutic categories. The principal areas in which nanomedical products have made an impact are cancer, CNS diseases, cardiovascular disease and infection control. The Summary Table gives estimates of the historical and current markets for these nanomedicine areas with a forecast through 2022.

The U.S. market is by far the largest in the global nanomedicine market and is set to continue to dominate the world marketplace; however, other national markets are expected to increase their shares over the next five years.

Reasons for Doing the Study

Global Nanorobots Market Research Report Covers (COVID-19 Analysis) Industry Research, Drivers, Top Trends, Global Analysis And Forecast to 2027 -…

Posted on November 10, 2020 by Prof Baldwin

Global Nanorobots Market Report Provides Detailed Study Of Industry Players, Business Strategies, Latest Developmental Trends, And Market Growth Rate

The global Nanorobots market report offers a thorough study of the market in the estimated period. The important players Bruker, Jeol, Thermo Fisher, Ginkgo Bioworks, Oxford Instruments, Ev Group, Imina Technologies, Toronto Nano Instrumentation, Klocke Nanotechnik, Kleindiek Nanotechnik, Xidex, Synthace, Park Systems, Smaract, Nanonics Imaging, Novascan Technologies, Angstrom Advanced, Hummingbird Scientific, Nt-Mdt Spectrum Instruments, Witecin the global Nanorobots market are mentioned along with their strong points as well as weak points in this report. It covers almost all aspects of the global Nanorobots market including challenges, demand, drivers, and opportunities. The report reviews the impact of these aspects on every market region as well. The value chain analysis and vendor list are also included in the global Nanorobots market report.

Ask For Free Sample PDF of Nanorobots Market Report

{We Provide Free Sample copy as per your Research Requirement, also including COVID 19 impact analysis}

The global Nanorobots market research report emphasizes the presentation of the in-depth market segments {Nanomanipulator, Bio-Nanorobotics, Magnetically Guided, Bacteria-Based}; {Nanomedicine, Biomedical}. The Nanorobots market is assessed on the basis of revenue (USD Million) as well. The performance of the important players, vendors, and suppliers influencing the market is also incorporated in the global Nanorobots market research report. The majority of the information, together with projected statistics, is presented in the report with the help of tables and graphics. This presentation technique helps the user to understand the market scenario in an easy way.

Various practical tools are used for assessing the development of the global Nanorobots market in the future period. The global Nanorobots market report offers an outline of the market on a global level. It helps users to decide their next business move and propel their businesses. The index growth and competitive framework of the global Nanorobots market over the projected period is involved while reviewing the Nanorobots market. The global Nanorobots market is also bifurcated regionally North America (the U.S., Canada, and Mexico), South America (Brazil, Argentina, Chile, Colombia), Europe (Spain, Russia, Germany, Italy, France, and UK), Asia-Pacific (Japan, Korea, India, China, Australia, and South-east Asia), The Middle East and Africa (Egypt, South Africa, GCC Countries) as well.

Enquire about COVID-19 Updates for This Report:https://www.marketdataanalytics.biz/global-nanorobots-market-industry-trends-and-forecast-to-2027-19156.html#inquiry-for-buying

Major Questions Answered in Report:1. Which are the growth factors likely to help the market reach to the next level?2. What is the expected growth rate during the forecast period?3. What are the latest opportunities and challenges for Nanorobots market in the future?4. Which are the key market players?

The global Nanorobots market is studied in terms of technology, topography, and consumers. The report also covers the market volume during the estimated period. The distinctiveness of the global Nanorobots market research report is the representation of the Nanorobots market at both the global and regional level.

Key Reasons for Purchasing Global Nanorobots Market Report:

New approaches and latest development trend that describe the structure of the market Advanced market breakdown structure Historical data and future market scope In-depth market analysis based on statistics, growth stimulators, and market developments Statistical data representation through figurative, numerical, and theoretical elaboration Report provides insight of the business and sales activities Key competitive players and regional distribution will help find prospective market analytics Report will strengthen the investors decision-making processes

To get more information on this Premium Report::https://www.marketdataanalytics.biz/global-nanorobots-market-industry-trends-and-forecast-to-2027-19156.html

See original here:
Global Nanorobots Market Research Report Covers (COVID-19 Analysis) Industry Research, Drivers, Top Trends, Global Analysis And Forecast to 2027 -...

Post COVID-19 Return to Growth Will Witness Growing Diabetic Population Emerge Into a Big Opportunity – GlobeNewswire

Posted on November 19, 2020 by Prof Baldwin

New York, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Foot Care Products Industry" - https://www.reportlinker.com/p090579/?utm_source=GNW Foot is a simple-looking yet complex structure of the human body made up of 26 bones and 33 joints and a complicated network of arteries, veins, and tendons. Feet are important for mobility, and better quality of life. As per studies, on average an individual walks about 100,000 miles in his lifetime. Foot care plays an important role in the overall foot health and following a good foot care regimen guarantees a comfortable foot all the time. Foot care refers to taking special preventative measures to stay away from foot problems such as cuts, calluses, sores and bunions. Foot care products are used for providing remedial and preventive foot and ankle care. Foot care products can help in treating a wide range of foot problems, including nail health, finger pain, toe pain, and heel pain. These problems can occur due to disease complications, general wear and tear, injury, or simply ill-fitting shoes. Rapidly changing lifestyle and fashion trends have significantly increased the exposure of the skin of the feet, thereby increasing the demand for foot care products. These products are more popular among women given the rising trend of open shoes and sandals. Consumers are now looking for sloughing scrubs, creams, cleansing lotions, and ointments for foot care that can deliver immediate results.

In the post COVID-19 period, growth will be driven by the aging population; high prevalence of diabetes; and growing awareness over the importance and interrelationship of foot and body mechanics that influence mobility, body posture, gait and balance. The shift towards preventive care in a bid to reduce healthcare costs and debilitating foot amputations in late-stage diabetic foot infections is helping drive demand for preventive foot care solutions. Complications due to diabetes are emerging into a massive healthcare burden driven by the epidemic increase in diabetes prevalence worldwide. Diabetic foot ulcers remain the leading cause of diabetic complication, already ranking among the top 10 cause of global disability, doctors visits & hospital admissions. Podology clinics where foot care is provided by professional podologists are poised to mushroom into a big opportunity foot care products. Proactive & preventive self-management foot care practices by patients will drive demand for consumer food care products designed for at-home consumption. Despite the availability of several products such as diabetic shoes that are designed to prevent high pressure points that could in turn lead to foot ulcers, scientists and researchers continue to push boundaries in this space with development of innovative, less-intrusive products that can both prevent and manage foot conditions in diabetics. One such area that has witnessed significant focus in recent years is Smart Socks, which help detect early signs of pressure on feet or other ailments that can lead to formation of diabetic foot ulcers. Research institutions and independent researchers have shown tremendous belief in the potential these socks have in the offing, and have made considerable progress to this end. Smart socks, which integrate temperature sensors, are capable of detecting infections through changes in temperature.

The launch of innovative and effective cosmetic foot care products such as foot mousse, electronic foot exfoliator, gel heel socks, cracked heel balm, rough skin remover, foot moisturizers, and massage creams, among others are helping encourage consumer spending. Natural and organic foot creams featuring potent ingredients such as vitamin e, coconut oil, glycerin, sea salts, shea butter, aloe-vera, papaya gel and cooling mints will grow in popularity. Women, given their unique genetic predisposition to foot ailments, represent the largest consumer cluster for foot care products. In addition, the rise of the new metropolitan male will drive demand for male foot care solutions. Advances in materials, 3d orthotics and fashionable orthotic footwear will also help expand revenue opportunities in the market. Asia-Pacific, a major market, will be led by factors such as growing emphasis of the educated middle class population on maintaining healthy feet that compliment high fashion footwear and the ensuing demand for cosmetic foot care solutions; rising incidence of foot infections such as scytalidium and dermatophytes due to improper hygiene standards; and rise in the number of patients with peripheral vascular diseases, neuropathy, hypothyroidism, diabetes and obesity that increase the risk of foot disorders.

Competitors identified in this market include, among others,

Read the full report: https://www.reportlinker.com/p090579/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE I-1

II. EXECUTIVE SUMMARY II-1

1. MARKET OVERVIEW II-1 Impact of Covid-19 and a Looming Global Recession II-1 Foot Care Products Market: A Prelude II-2 Foot Facts & Figures II-3 Foot Care Product Categories II-4 Market Outlook II-5 Geographic Landscape II-6 Geographic Landscape World Brands II-8

2. FOCUS ON SELECT PLAYERS II-9

3. MARKET TRENDS & DRIVERS II-11 Growing Focus on Self Care Boost OTC Foot Care Products II-11 Exhibit 1: Frequency of Foot Care Products Usage: 2019 II-11 Manufacturers Focus on Enabling Self-Care, Educating Customers II-12 Women: An Important Consumer Cluster II-12 Exhibit 2: Reasons for Using Foot Care Products among Women II-13 Rising Interest in Grooming Among Men Signals Opportunities II-14 Exhibit 3: Foot Care Products Usage Frequency (In %) Among Male Consumers by Age Group II-14 Product Innovations Steer Growth II-15 Growing Use of Natural and Organic Ingredients II-17 Nanomedicine to Improve Anti-Fungal Treatment II-17 E-Retailing Expands Growth Opportunities II-18 Exhibit 4: Factors Influencing Online Purchase Decision - Percentage Share Breakdown by Consumer Preferences II-19 Significance of Foot-Care in Diabetic Population II-19 Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Foot Care Products II-20 Exhibit 5: World Diabetes and Population Statistics (2019, 2030 & 2045) II-21 Exhibit 6: World Diabetes Prevalence (2000-2019) II-22 Smart Socks: The Future of Diabetic Foot Care? II-22 Obese Population: A Weighty Market Driver II-23 Exhibit 7: Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P II-25 Aging Population Offers Growth Prospects II-26 Exhibit 8: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 II-27 Emerging Middle Class in Developing Countries to Fuel Market II-27 Exhibit 9: Global Middle Class Population (In Million) by Region for the Years 2020, 2025 and 2030 II-28 Natural Remedies Remain a Challenge II-29 GENERAL FOOT PROBLEMS II-29

4. GLOBAL MARKET PERSPECTIVE II-31 Table 1: World Current & Future Analysis for Foot Care Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-31

Table 2: World Historic Review for Foot Care Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-32

Table 3: World 15-Year Perspective for Foot Care Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 II-33

Table 4: World Current & Future Analysis for Foot Creams by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-34

Table 5: World Historic Review for Foot Creams by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-35

Table 6: World 15-Year Perspective for Foot Creams by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 II-36

Table 7: World Current & Future Analysis for Foot Cleansing Lotions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-37

Table 8: World Historic Review for Foot Cleansing Lotions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-38

Table 9: World 15-Year Perspective for Foot Cleansing Lotions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 II-39

Table 10: World Current & Future Analysis for Slough Scrub Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-40

Table 11: World Historic Review for Slough Scrub Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-41

Table 12: World 15-Year Perspective for Slough Scrub Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 II-42

Table 13: World Current & Future Analysis for Foot Repair Ointments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-43

Table 14: World Historic Review for Foot Repair Ointments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-44

Table 15: World 15-Year Perspective for Foot Repair Ointments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 II-45

Table 16: World Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-46

Table 17: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-47

Table 18: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 II-48

Table 19: World Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-49

Table 20: World Historic Review for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-50

Table 21: World 15-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 II-51

Table 22: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-52

Table 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-53

Table 24: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 II-54

III. MARKET ANALYSIS III-1

GEOGRAPHIC MARKET ANALYSIS III-1

UNITED STATES III-1 Market Overview III-1 Growing Incidence of Diabetes Boost Prospects for Foot Care Creams III-1 Exhibit 10: Diabetes and Population Statistics in North America and Caribbean Region (2019, 2030 & 2045) III-3 Exhibit 11: Diabetes Prevalence by Ethnicity: 2019 III-3 Exhibit 12: Diabetes Prevalence in the US: Percentage Share Breakdown of Number of Diabetics by Age Group for 2019 III-4 Aging Population Support Growth III-4 Exhibit 13: Population of 65+ Age Group (in Thousands) in the US for 2019 and 2030 III-4 Alarming Rise in Obesity to Drive Demand III-5 A Glance at Obesity Statistics III-5 Exhibit 14: Prevalence of Obesity Among Adults (20 and above) in the US: 2000 III-6 Rise in Incidence of Athlete?s foot to Drive Antifungal Cream Sales III-6 Market Analytics III-7 Table 25: USA Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-7

Table 26: USA Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-8

Table 27: USA 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-9

Table 28: USA Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-10

Table 29: USA Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-11

Table 30: USA 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-12

CANADA III-13 Table 31: Canada Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-13

Table 32: Canada Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-14

Table 33: Canada 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-15

Table 34: Canada Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-16

Table 35: Canada Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-17

Table 36: Canada 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-18

JAPAN III-19 Table 37: Japan Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-19

Table 38: Japan Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-20

Table 39: Japan 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-21

Table 40: Japan Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-22

Table 41: Japan Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-23

Table 42: Japan 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-24

CHINA III-25 Market Overview III-25 Market Analytics III-26 Table 43: China Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-26

Table 44: China Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-27

Table 45: China 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-28

Table 46: China Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-29

Table 47: China Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-30

Table 48: China 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-31

EUROPE III-32 Market Overview III-32 Exhibit 15: Diabetes and Population Statistics in Europe (2019, 2030 & 2045) III-32 Market Analytics III-33 Table 49: Europe Current & Future Analysis for Foot Care Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 III-33

Table 50: Europe Historic Review for Foot Care Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-34

Table 51: Europe 15-Year Perspective for Foot Care Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 III-35

Table 52: Europe Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-36

Table 53: Europe Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-37

Table 54: Europe 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-38

Table 55: Europe Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-39

Table 56: Europe Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-40

Table 57: Europe 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-41

FRANCE III-42 Table 58: France Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-42

Table 59: France Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-43

Table 60: France 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-44

Table 61: France Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-45

Table 62: France Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-46

Table 63: France 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-47

GERMANY III-48 Table 64: Germany Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-48

Table 65: Germany Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-49

Table 66: Germany 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-50

Table 67: Germany Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-51

Table 68: Germany Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-52

Table 69: Germany 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-53

ITALY III-54 Table 70: Italy Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-54

Table 71: Italy Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-55

Table 72: Italy 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-56

Table 73: Italy Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-57

Table 74: Italy Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-58

Table 75: Italy 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-59

UNITED KINGDOM III-60 Market Overview III-60 Diabetic Foot Ulcers in UK III-60 Market Analytics III-61 Table 76: UK Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-61

Table 77: UK Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-62

Table 78: UK 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-63

Table 79: UK Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-64

Table 80: UK Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-65

Table 81: UK 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-66

SPAIN III-67 Table 82: Spain Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-67

Table 83: Spain Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-68

Table 84: Spain 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-69

Table 85: Spain Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-70

Table 86: Spain Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-71

Table 87: Spain 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-72

RUSSIA III-73 Table 88: Russia Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-73

How Nanomedicine is Going Green and Fighting Superbugs – CareDash News

Posted on February 19, 2020 by Prof Baldwin

Nanomaterials are materials with one dimension less than 100 nanometers. A nanometer is one-billionth of a meter. Professor Thomas Webster directs the Nanomedicine Laboratory at Northeastern University. His lab designs, synthesizes, and evaluates nanomaterials for various medical implant applications. CareDash CEO and Managing Editor Ted Chan interviewed Dr. Webster about nanotech innovation.

We focus on the synthesis, design, and evaluation of nanomaterials (that is, tubes, particles, etc. with dimensions usually less than 100 nm) in medicine. Specifically, we were the first group to demonstrate increased tissue growth (such as bone, cartilage, vascular, bladder, nervous system, etc.) on nanomaterials compared to conventional implants. We were also the first group to report decreased infection on nanomaterials compared to conventional implants, even without the use of drugs. We have also been pioneering the use of implantable nanosensors to detect disease, communicate such information to a handheld device, and kill the disease on-demand.

As just one example, we have a growing alarming number of antibiotic-resistant infections that are crippling our healthcare system. In fact, the U.S. Centers for Disease Control has predicted that more people will die from antibiotic-resistant infections than all cancers combined by 2050. We created this problem, and we can solve it. So, in simple terms, we are killing bacteria using nanoparticles, but not antibiotics. We can even kill antibiotic-resistant bacteria with nanoparticles, whereas antibiotics fail. Decreasing infection from any bacteria, especially antibiotic-resistant bacteria, will significantly increase health.

In addition to those medical advances mentioned above (implantable sensors, nanoparticles that can kill antibiotic-resistant bacteria, nanomaterials to increase tissue growth, etc.), I am particularly excited about green nanomedicine.

Green nanomedicine is where we can use natural materials to create medical devices and nanoparticles. This is important since a significant portion of the "plastic island" in the Pacific Ocean is composed of plastics from the medical community, yet very few people are studying green biomaterials or green nanomedicine. We are here at Northeastern Nanomedicine Laboratory. We have been creating green medical devices and green nanoparticles, which is saving our environment and are more effective in their function than the respective conventional materials.

Persistence. We have started over 13 companies with over 23 FDA approved implants. Research is hard enough, but getting the funding to commercialize your products is even harder. I have learned throughout my career in so many ways never to give up, and if you believe in technology, persist until it is saving human lives.

Dr. Webster is a Keynote Speaker at the 2ndBiomedical Engineering and Instrumentation Summit(BEIS 2020), a conference organized to promote awareness and enhance research in biomedical engineering. BEIS 2020 will be held on July 20-22, 2020, in Boston, MA.

Disclosure: CareDash is a media partner of the BEIS Summit at which Dr. Webster is a keynote speaker in 2020. Dr. Webster and CareDash have no financial affiliation.

You can also tweet us questions and comments@caredash.

Read this article:
How Nanomedicine is Going Green and Fighting Superbugs - CareDash News

Oxford Performance Materials’ OsteoFab 3D Printed PEKK Technology Focus of Study Published in The Spine Journal – OrthoSpineNews

Posted on February 21, 2020 by Prof Baldwin

SOUTH WINDSOR, CONN. (PRWEB)FEBRUARY 17, 2020

Oxford Performance Materials, Inc. (OPM), an industry leader in advanced materials science and high-performance additive manufacturing (HPAM), announced today the publication of A Comparative Study of Three Biomaterials in an Ovine Defect Model: A TETRAfuse PEKK Study in The Spine Journal. 1,2,3 This study examined the in vivo material characteristics of polyetheretherketone (PEEK), titanium-coated PEEK, and 3D printed polyetherketoneketone (PEKK) in a sheep model. In comparison with PEEK, the PEKK implants displayed bone ingrowth, no fibrotic tissue formation, a significant increase in bony apposition over time, and a significantly higher push-out strength.

Conventionally, PEEK and Ti-coated PEEK have been used as standard biomaterials for implants like spinal interbody cages, but recent shortcomings in these materials have led to adoption of newer, more innovative technologies. Although PEEK shows an elastic modulus comparable to that of cortical bone, literature has illustrated that it consistently prompts a fibrotic and inflammatory tissue response, preventing it from integrating with host tissue. And while titanium exhibits similar osseointegrative properties when compared to PEKK, it is substantially stiffer than cortical bone and it is radiopaque, which makes bone fusion assessments difficult as the bone/implant interface is often obscured in post-operative imaging. With titanium coated PEEK implants, these drawbacks still exist but with the added risks of delamination of the titanium coating, subsidence, and the generation of wear debris.

The results reported by The Spine Journal were gratifying and support the comparative benefits of 3D printed PEKK implants that we have been hearing from surgeons for some time, now, said Scott DeFelice, CEO. OPMs OsteoFab technology platform is increasingly recognized as a best of solution for CMF and spinal implants, and we will be launching our unique 3D printed suture anchor product in the coming weeks.

3D printed PEKK delivers high mechanical integrity, radiographic visibility, and osseointegration, as well as inherent antibacterial characteristics.4 In this Spine Journal study, PEKK demonstrated a significantly higher push-out force when compared to PEEK at 8 and 16 weeks post-implantation and also had notably greater bone attachment following pushout when compared to PEEK and Ti-coated PEEK. From a histological standpoint, 3D printed PEKK also showed substantial bone growth. Within a 2mm radius of the implant, 3D printed PEKK exhibited the highest bone ongrowth percentage when compared to PEEK and Ti-coated PEEK at both the 8- and 16-week endpoints.

By directly comparing the three implant materials in an in vivo model, the study showed clear evidence of the performance characteristics at the bone-implant interface. In this instance, 3D printed PEKK presented a high propensity for bone-ingrowth, no radiographic interference, and a material structure that allowed for an increase of integration of cancellous bone into the implant. In a clinical scenario, 3D printed PEKK implants could improve the effectiveness of spinal fusion procedures by promoting osseointegration and decreasing the chance of complications associated with PEEK and Ti-coated PEEK.

Since 2013, OPM has been manufacturing patient-specific cranial and facial implant devices that have been distributed world-wide. In addition to over 2,300 craniomaxillofacial implants, OPM has 3D printed over 70,000 OsteoFab implants under a number of 510(k) clearances and just recently entered the sports medicine arena with a soft tissue fixation device. As the pendulum shifts away from traditional material solutions, OsteoFab 3D printed PEKK is proving to be a robust alternative with a rapidly growing user base.

About Oxford Performance Materials, Inc.

Oxford Performance Materials was founded in 2000 to exploit and commercialize the worlds highest performing thermoplastic, PEKK (poly-ether-ketone-ketone). OPMs Materials business has developed a range of proprietary, patented technologies for the synthesis and modification of a range of PAEK polymers that are sold under its OXPEKK brand for biomedical and industrial applications. The Company is a pioneer in 3D printing. OPM Biomedicals OsteoFab technology is in commercial production in numerous orthopedic implant applications, including cranial, facial, spinal, and sports medicine devices. OPM is the first and only company to receive FDA 510(k) clearance to manufacture 3D printed patient-specific polymeric implants and has six 510(k) clearances in its portfolio. OPM Industrial produces 3D printed OXFAB production parts for highly demanding applications in the energy, transportation and semiconductor markets. OXFAB structures offer significant weight, cost, and time-to-market reductions that are defined in a set of specified performance attributes in the exhaustive OPM B-Basis database, developed in conjunction with NASA. For more information, please visit:http://www.oxfordpm.com

Company Contact:Willow JohndrowDirector of Marketing860.656.9442

References1. Cheng, PhD B, Jaffee S, Swink I, Averick, PhD S, Horvath S, Zhukauskas, PhD R et al. A Comparative Study of Three Biomaterials in an Ovine Bone Defect Model: A TETRAfuse PEKK Study. The Spine Journal. 2019. doi: 10.1016/j.spinee.2019.10.0032. RESULTS paragraph from the Study abstract reads: PEKK implants demonstrated bone ingrowth, no radiographic interference, no fibrotic tissue membrane formation, significant increase in bony apposition over time, and significantly higher push-out strength compared to standard PEEK. The PEKK implant displayed bone growth characteristics comparable to Ti-coated PEEK with significant improvements in implant integrity and radiographic properties.3. Note: TETRAfuse is a Registered Trademark of RTI Surgical, Inc. and the tradename for RTIs spinal implants that are additively manufactured by Oxford Performance Materials, Inc. using OPMs proprietary OsteoFab technology platform. TETRAfuse was awarded a 2019 MedTech Breakthrough Award for Best New Technology Solution Orthopedics and a 2018 Spine Technology Award from Orthopedics This Week.4. Wang M, Bhardwaj B, Webster T; Antibacterial properties of PEKK for orthopedic applications. Intl Journal of Nanomedicine. 2017: 12 6471-6476.

Read the original post:
Oxford Performance Materials' OsteoFab 3D Printed PEKK Technology Focus of Study Published in The Spine Journal - OrthoSpineNews

Select Page ::